By Kenneth L. Waggoner, Chief Executive Officer, President, General Counsel and Chairman of the Board, PharmaCyte Biotech Scientific research is a cooperative enterprise. Researchers working today are standing on the shoulders of those who have gone before, and they are paving the way from the next generation of scientists. Today’s researchers attend conferences and exchange
Read more →PharmaCyte Biotech will partner with the University of Technology Sydney (UTS) to co-develop the company’s preclinical treatment for insulin-dependent diabetes that uses its Cell-in-a-Box® technology. The value of the collaboration was not disclosed. The diabetes treatment consists of Melligen cells—human
Read more →SILVER SPRING, Md.—Ascites, which is the buildup of fluid in the abdominal cavity, is called malignant ascites when caused by cancer and accounts for 10 percent of people with ascites. Malignant ascites appears most often in people with breast,
Read more →Newswise — Malignant ascites fluid accumulation is problematic for patients with pancreatic and other abdominal cancers. As this fluid accumulates, the abdomen becomes swollen and painful. In addition, because it contains cancer cells, new tumors can form at locations in a patient away from the source of the original cancer. If left untreated, malignant ascites
Read more →Before the curtains even closed on the 2015 American Society of Clinical Oncology annual meeting, attention is turning to the American Diabetes Association’s (ADA) 75th Scientific Sessions, which begin Friday in Boston. Abstract titles suggest presentations will address not only the raft of current drug development efforts and large cardiovascular outcome trials (CVOT) that have
Read more →PharmaCyte Biotech’s recently appointed CEO Kenneth L. Waggoner, is solely focused on hitting major milestones and marks 2015 as a banner year for PharmaCyte Biotech, Inc. (OTCQB:PMCB), a Silver Spring, MD-based clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®.
Read more →PharmaCyte Biotech Inc.
3960 Howard Hughes Parkway, Suite 500
Las Vegas, Nevada 89169
Office Number: 917.595.2850
Facsimile Number: 917.595.2851
Email: [email protected]
